As per this study the Global Point-Of-Care Cholesterol Monitoring Device Market was valued USD 446.31 MN (by revenue) in 2022 and is anticipated to reach USD 592.26 MN by 2030 with a CAGR of 3.6%.
Point of care cholesterol monitoring device refers to the medical diagnostic devices used to measure level of total cholesterol (TC), high-density lipoprotein (HDL) cholesterol, low-density lipoprotein (LDL) cholesterol and triglycerides within the blood. These are cost-effective, handheld devices that offer rapid, accurate results and thus used at hospitals, clinics, diagnostics centers, ambulatory surgical care and even at patient's home.
Market Dynamics
The market is projected to witness substantial growth owing to the rising incidence of cardiovascular diseases. Growing geriatric population, changing lifestyle, excessive smoking habits, and improper eating habits are some of the factors pushing demand for frequent cholesterol level monitoring. This, in turn, is boosting the market growth. Owing to portable, inexpensive, rapid, accurate result delivering device is fostering its demand across hospitals, clinics, and other healthcare facilities.
This detailed market study is centered on the data obtained from multiple sources and is analyzed using numerous tools including porter's five forces analysis, market attractiveness analysis and value chain analysis. These tools are employed to gain insights of the potential value of the market facilitating the business strategists with the latest growth opportunities. Additionally, these tools also provide a detailed analysis of each application/product segment in the global market of point-of-care cholesterol monitoring device.
Market Segmentation
The broad point-of-care cholesterol monitoring device market has been sub-grouped into type, application and end-user. The report studies these subsets with respect to the geographical segmentation. The strategists can gain a detailed insight and devise appropriate strategies to target specific market. This detail will lead to a focused approach leading to identification of better opportunities.
By Product
- Instruments (Teble-top Analyzers, Hand-held Analyzers)
- Testing Kits
By Technology
- Electrochemical Biosensor
- Reflectance Photometry
By Application
- Dyslipidemia
- Atherosclerosis
- Hypercholestrolemia
- Other
By End User
- Hospitals
- Diagnostics-centers & Laboratory
- Ambulatory Surgical Centers
- Home Care Sittings
Regional Analysis
Furthermore, the report comprises of the geographical segmentation, which mainly focuses on current and forecast demand for point-of-care cholesterol monitoring device in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The report further focuses on demand for individual application segments in all the regions.
Global Point-Of-Care Cholesterol Monitoring Device Market Share by Region (Representative Graph)
The report also covers detailed competitive landscape including company profiles of key players operating in the global market. The key players in the Point-Of-Care Cholesterol Monitoring Device market includes F.Hoffmann-La Roche Ltd., About Laboratories, Abaxis Inc (Sub of Zoets Inc.), DiaSye Diagnostic Systems GmbH, ACON Laboratories, PTS Diagnostics, Bioptik Technology Inc., SD Biosensor, Inc, Jant Pharmacal Corporation Inc, Nova Biomedical Corporation, Beckman Coulter Inc. (Sub of Danaher Corporation), Samsung Health care Inc. An in-depth view of the competitive outlook includes future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other developments with information in terms of H.Q.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.